New MRI software aims to speed up cancer needle procedures

NCT ID NCT03432936

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Mayo Clinic Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests new MRI guidance software called Philips Interventional iSuite. Doctors will use it to guide needles for biopsies and tumor ablations in 12 patients already scheduled for these procedures. The goal is to see if the software helps place needles faster and more accurately compared to current CT-guided methods.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Philips Interventional iSuite software (device)
What this could lead to: If it works, this software could make MRI-guided needle procedures faster and easier for doctors, potentially improving precision in cancer biopsies and treatments.
What could go wrong: This is a very small study (12 people) testing software usability, not patient outcomes. It may not lead to any change in practice or show clear benefit over current methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER TUMOR

Contacts and locations

Locations

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.